NPM1 and acute myeloid leukemia: In accordance, going beyond the 2016 WHO classification [103], the current 2022 International Consensus Classification and the fifth WHO classification of myeloid neoplasms both classify NPM1-mutated AML as such, independently of the previous clinical history [22,38].